Zobrazeno 1 - 10
of 159
pro vyhledávání: '"Jean Noël Trochu"'
Autor:
Guillaume Lamirault, Imen Fellah-Hebia, Catherine Chevalier, Isabelle Guisle, Béatrice Guyomarc'h, Aude Solnon, Jean-Baptiste Gourraud, Laurent Desprets, Selim Abbey, Christophe Leclercq, Paul Bru, Antoine Milhem, Olivier Billon, Frederic Anselme, Arnaud Savouré, Jean-Noël Trochu, Rémi Houlgatte, Gilles Lande, Marja Steenman
Publikováno v:
Journal of Molecular and Cellular Cardiology Plus, Vol 8, Iss , Pp 100077- (2024)
Heart failure (HF) increases the risk of developing atrial fibrillation (AF), leading to increased morbidity and mortality. Therefore, better prediction of this risk may improve treatment strategies. Although several predictors based on clinical data
Externí odkaz:
https://doaj.org/article/3be3a7a482fa4e37ab6fd71847435149
Autor:
Matthieu Wargny, Mikaël Croyal, Stéphanie Ragot, Elise Gand, David Jacobi, Jean-Noël Trochu, Xavier Prieur, Cédric Le May, Thomas Goronflot, Bertrand Cariou, Pierre-Jean Saulnier, Samy Hadjadj, for the SURDIAGENE study group
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-11 (2022)
Abstract Background Heart failure (HF) is a growing complication and one of the leading causes of mortality in people living with type 2 diabetes (T2D). Among the possible causes, the excess of red meat and the insufficiency of vegetables consumption
Externí odkaz:
https://doaj.org/article/a4be4d68f8c84934a3b8a63f3457620d
Autor:
Justine Dhot, Marine Ferron, Valentine Prat, Antoine Persello, David Roul, David Stévant, Damien Guijarro, Nicolas Piriou, Virginie Aillerie, Angélique Erraud, Gilles Toumaniantz, Morteza Erfanian, Angela Tesse, Amandine Grabherr, Laurent Tesson, Séverine Menoret, Ignacio Anegon, Jean‐Noël Trochu, Marja Steenman, Michel De Waard, Bertrand Rozec, Benjamin Lauzier, Chantal Gauthier
Publikováno v:
ESC Heart Failure, Vol 7, Iss 6, Pp 4159-4171 (2020)
Abstract Aims Diastolic dysfunction is common in cardiovascular diseases, particularly in the case of heart failure with preserved ejection fraction. The challenge is to develop adequate animal models to envision human therapies in the future. It has
Externí odkaz:
https://doaj.org/article/303759f709374a3a807f6f14fd31e462
Autor:
Nicolas Piriou, Lara Marteau, Florence Kyndt, Jean Michel Serfaty, Claire Toquet, Laurianne Le Gloan, Karine Warin‐Fresse, Damien Guijarro, Thierry Le Tourneau, Emilie Conan, Aurélie Thollet, Vincent Probst, Jean‐Noël Trochu
Publikováno v:
ESC Heart Failure, Vol 7, Iss 4, Pp 1520-1533 (2020)
Abstract Aims Several data suggest that acute myocarditis could be related to genetic variants involved in familial cardiomyopathies, particularly arrhythmogenic cardiomyopathy, but the management of patients with acute myocarditis and their families
Externí odkaz:
https://doaj.org/article/d110a1a516e9430780807338e88546d5
Autor:
Patrice Cacoub, Gabriel Choukroun, Alain Cohen-Solal, Elisabeth Luporsi, Laurent Peyrin-Biroulet, Katell Peoc’h, Valérie Andrieu, Sigismond Lasocki, Hervé Puy, Jean-Noël Trochu
Publikováno v:
Nutrients, Vol 14, Iss 5, p 1039 (2022)
Iron deficiency (ID) in patients with chronic inflammatory diseases is frequent. However, under-diagnosis is also frequent due to the heterogeneity between guidelines from different medical societies. We applied a common definition for the diagnosis
Externí odkaz:
https://doaj.org/article/be5f921c3af04ddc9fa8d5e6be6794ee
Autor:
Patrice Cacoub, Gabriel Choukroun, Alain Cohen‐Solal, Elisabeth Luporsi, Laurent Peyrin‐Biroulet, Katell Peoc'h, Valérie Andrieu, Sigismond Lasocki, Hervé Puy, Jean‐Noël Trochu
Publikováno v:
Journal of Internal Medicine
Journal of Internal Medicine, Wiley, 2022, 292 (4), pp.542--556. ⟨10.1111/joim.13503⟩
Journal of Internal Medicine, Wiley, 2022, 292 (4), pp.542--556. ⟨10.1111/joim.13503⟩
International audience; Iron deficiency is frequent in patients with chronic inflammatory conditions (e.g., chronic heart failure, chronic kidney disease, cancers, and bowel inflammatory diseases). Indeed, high concentrations of inflammatory cytokine
Autor:
Xavier Capdevila, Sigismond Lasocki, Alexis Duchalais, Jean-Christophe Rigal, Patrice Mertl, Pierre Ghewy, Frédéric Farizon, Thomas Lanz, Axel Buckert, Samia Belarbia, Jean-Noël Trochu, Patrice Cacoub
Publikováno v:
Anesthesia & Analgesia.
Autor:
Sanjiv J Shah, Barry A Borlaug, Eugene S Chung, Donald E Cutlip, Philippe Debonnaire, Peter S Fail, Qi Gao, Gerd Hasenfuß, Rami Kahwash, David M Kaye, Sheldon E Litwin, Philipp Lurz, Joseph M Massaro, Rajeev C Mohan, Mark J Ricciardi, Scott D Solomon, Aaron L Sverdlov, Vijendra Swarup, Dirk J van Veldhuisen, Sebastian Winkler, Martin B Leon, Joseph Akar, Jiro Ando, Toshihisa Anzai, Masanori Asakura, Steven Bailey, Anupam Basuray, Fabrice Bauer, Martin Bergmann, John Blair, Jeffrey Cavendish, Eugene Chung, Maja Cikes, Ira Dauber, Erwan Donal, Jean-Christophe Eicher, Peter Fail, James Flaherty, Xavier Freixa, Sameer Gafoor, Zachary Gertz, Robert Gordon, Marco Guazzi, Cesar Guerrero-Miranda, Deepak Gupta, Finn Gustafsson, Cyrus Hadadi, Emad Hakemi, Louis Handoko, Moritz Hass, Jorg Hausleiter, Christopher Hayward, Gavin Hickey, Scott Hummel, Imad Hussain, Richard Isnard, Chisato Izumi, Guillaume Jondeau, Elizabeth Juneman, Koichiro Kinugawa, Robert Kipperman, Bartek Krakowiak, Selim Krim, Joshua Larned, Gregory Lewis, Erik Lipsic, Anthony Magalski, Sula Mazimba, Jeremy Mazurek, Michele McGrady, Scott Mckenzie, Shamir Mehta, John Mignone, Hakim Morsli, Ajith Nair, Thomas Noel, James Orford, Kishan Parikh, Tiffany Patterson, Martin Penicka, Mark Petrie, Burkert Pieske, Martijn Post, Philip Raake, Alicia Romero, John Ryan, Yoshihiko Saito, Takafumi Sakamoto, Yasushi Sakata, Michael Samara, Kumar Satya, Andrew Sindone, Randall Starling, Jean-Noël Trochu, Bharathi Upadhya, Jan van der Heyden, Vanessa van Empel, Amit Varma, Amanda Vest, Tobias Wengenmayer, Ralf Westenfeld, Dirk Westermann, Kazuhiro Yamamoto, Andreas Zirlik
Publikováno v:
LANCET, 399(10330), 1130-1140. ELSEVIER SCIENCE INC
REDUCE LAP-HF II investigators 2022, ' Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II) : a randomised, multicentre, blinded, sham-controlled trial ', The Lancet, vol. 399, no. 10330, pp. 1130-1140 . https://doi.org/10.1016/S0140-6736(22)00016-2
The Lancet, 399(10330), 1130-1140. Elsevier Limited
REDUCE LAP-HF II investigators 2022, ' Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II) : a randomised, multicentre, blinded, sham-controlled trial ', The Lancet, vol. 399, no. 10330, pp. 1130-1140 . https://doi.org/10.1016/S0140-6736(22)00016-2
The Lancet, 399(10330), 1130-1140. Elsevier Limited
Background Placement of an interatrial shunt device reduces pulmonary capillary wedge pressure during exercise in patients with heart failure and preserved or mildly reduced ejection fraction. We aimed to investigate whether an interatrial shunt can
Autor:
Damien Logeart, Thibaud Damy, Maxime Doublet, Muriel Salvat, Christophe Tribouilloy, Fabrice Bauer, Jean-Christophe Eicher, François Picard, Gérald Roul, Jean-Noël Trochu, Pascal De Groote, Nicolas Bihry, Emmanuelle Berthelot, Guillaume Jondeau, Marie-France Seronde, François Roubille, Richard Isnard
Publikováno v:
Archives of cardiovascular diseases.
Heart failure (HF) registries include rich data on patient inclusion characteristics, but follow-up information is often incomplete. Medicoadministrative databases may provide less clinical information than registries, e.g. on left ventricular ejecti
Autor:
Laure de Decker, Jean Noël Trochu, Bastien Genet, Anne Sophie Boureau, Gilles Berrut, Olivier Hanon
Publikováno v:
Gériatrie et Psychologie Neuropsychiatrie du Viellissement. 19:137-147
Glucose and sodium tubular reabsorption inhibitors, or gliflozins, are a new therapeutic class. Their novel mechanism of action involves inhibition of a glucose and Na+ reabsorption co-transporter in the renal proximal tubule. They reduce blood gluco